Home
News

News

All News
By Year:
2019
2018
2017
2016

Jan 29, 2018

DiaMedica to Present at the 14th Annual Noble Investor Conference

Jan 18, 2018

DiaMedica Letter to Shareholders

Dec 21, 2017

DiaMedica Therapeutics Announces Results of Annual General and Special Meeting of Shareholders

Dec 18, 2017

DiaMedica Therapeutics Completes Non-Brokered Private Placement

Dec 13, 2017

DiaMedica Therapeutics Announces Non-Brokered Private Placement

Nov 22, 2017

DiaMedica Therapeutics Announces Ethics Committee Clearance at First Site to Initiate REMEDY Phase 2 Trial for Acute Ischemic Stroke

Nov 7, 2017

DiaMedica Therapeutics Announces Publication of Positive Clinical Results for DM199 in the International Journal of Clinical Trials

Oct 31, 2017

DiaMedica Announces Dr. Robert Stanton as Scientific Advisor for Upcoming Chronic Kidney Disease Trials

Oct 27, 2017

DiaMedica Therapeutics Announces the Early Exercise of Warrants from Strategic Investor

Sep 11, 2017

DiaMedica Announces the Initiation of Phase 2 Trial Evaluating DM199 (Recombinant Human KLK1) in Patients with Acute Ischemic Stroke